Thomas Schirrmann

3.8k total citations
69 papers, 2.8k citations indexed

About

Thomas Schirrmann is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Ecology. According to data from OpenAlex, Thomas Schirrmann has authored 69 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Radiology, Nuclear Medicine and Imaging, 49 papers in Molecular Biology and 14 papers in Ecology. Recurrent topics in Thomas Schirrmann's work include Monoclonal and Polyclonal Antibodies Research (50 papers), Glycosylation and Glycoproteins Research (22 papers) and Protein purification and stability (17 papers). Thomas Schirrmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (50 papers), Glycosylation and Glycoproteins Research (22 papers) and Protein purification and stability (17 papers). Thomas Schirrmann collaborates with scholars based in Germany, United States and France. Thomas Schirrmann's co-authors include Michael Hust, André Frenzel, Stefan Dübel, Torsten Meyer, Holger Thie, Gabriele Pecher, Mark Schütte, Andrea L. J. Marschall, Saskia Helmsing and Jonas Kügler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Thomas Schirrmann

68 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Schirrmann Germany 31 1.9k 1.8k 561 425 310 69 2.8k
André Frenzel Germany 21 1.3k 0.7× 1.1k 0.6× 448 0.8× 262 0.6× 259 0.8× 50 2.0k
Dirk Saerens Belgium 22 1.9k 1.0× 1.9k 1.1× 760 1.4× 214 0.5× 228 0.7× 32 2.9k
John McCafferty United Kingdom 19 3.2k 1.7× 3.3k 1.9× 775 1.4× 636 1.5× 331 1.1× 24 4.1k
Angray S. Kang United Kingdom 26 2.6k 1.4× 2.3k 1.3× 1.0k 1.8× 552 1.3× 247 0.8× 71 4.3k
Hans J. de Haard Netherlands 13 1.4k 0.7× 1.6k 0.9× 637 1.1× 160 0.4× 435 1.4× 15 2.3k
Shalom Stahl Sweden 23 1.3k 0.7× 988 0.6× 242 0.4× 220 0.5× 341 1.1× 42 2.2k
Cécile Vincke Belgium 25 1.6k 0.8× 1.9k 1.1× 644 1.1× 108 0.3× 550 1.8× 53 2.8k
Emmanuel Bajyana Songa Belgium 9 1.5k 0.8× 1.7k 0.9× 631 1.1× 176 0.4× 264 0.9× 13 2.6k
Katja Conrath Belgium 25 3.1k 1.6× 3.3k 1.8× 1.3k 2.3× 295 0.7× 412 1.3× 28 4.7k
Ian M. Tomlinson United Kingdom 22 3.2k 1.6× 3.6k 2.0× 1.4k 2.5× 379 0.9× 322 1.0× 31 4.7k

Countries citing papers authored by Thomas Schirrmann

Since Specialization
Citations

This map shows the geographic impact of Thomas Schirrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schirrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schirrmann more than expected).

Fields of papers citing papers by Thomas Schirrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schirrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schirrmann. The network helps show where Thomas Schirrmann may publish in the future.

Co-authorship network of co-authors of Thomas Schirrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schirrmann. A scholar is included among the top collaborators of Thomas Schirrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schirrmann. Thomas Schirrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kühn, Philipp, Sabrina Petralla, Fatemeh Dabbagh, et al.. (2025). A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers. mAbs. 17(1). 2563758–2563758. 1 indexed citations
2.
Abassi, Leila, Federico Bertoglio, Thomas Schirrmann, et al.. (2023). Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns. Viruses. 15(11). 2153–2153. 2 indexed citations
3.
Klausz, Katja, André Frenzel, Steffen Krohn, et al.. (2023). Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells. Frontiers in Immunology. 14. 10 indexed citations
4.
Dübel, Stefan, Michael Hust, André Frenzel, & Thomas Schirrmann. (2020). Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19. BIOspektrum. 26(4). 444–446. 2 indexed citations
5.
Weber, Susanne, et al.. (2016). Selection of Recombinant Human Antibodies. Advances in experimental medicine and biology. 917. 23–54. 9 indexed citations
6.
Kügler, Jonas, Doris Meier, André Frenzel, et al.. (2015). Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnology. 15(1). 10–10. 100 indexed citations
7.
Marschall, Andrea L. J., Congcong Zhang, André Frenzel, et al.. (2014). Delivery of antibodies to the cytosol. mAbs. 6(4). 943–956. 70 indexed citations
8.
Schirrmann, Thomas, André Frenzel, Lars Lindén, et al.. (2014). Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform. mAbs. 6(2). 367–380. 8 indexed citations
9.
Frenzel, André, Michael Hust, & Thomas Schirrmann. (2013). Expression of Recombinant Antibodies. Frontiers in Immunology. 4. 217–217. 255 indexed citations
10.
Marschall, Andrea L. J., et al.. (2011). Targeting antibodies to the cytoplasm. mAbs. 3(1). 3–16. 95 indexed citations
11.
Meyer, Torsten, Jochen Meens, Thomas Schirrmann, et al.. (2010). Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. Veterinary Microbiology. 147(1-2). 162–169. 27 indexed citations
12.
Hust, Michael, Torsten Meyer, Bernd Voedisch, et al.. (2010). A human scFv antibody generation pipeline for proteome research. Journal of Biotechnology. 152(4). 159–170. 107 indexed citations
13.
Schütte, Mark, Philippe Thullier, Thibaut Pelat, et al.. (2009). Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus. PLoS ONE. 4(8). e6625–e6625. 57 indexed citations
14.
Rybak, S.M., Marco Arndt, Thomas Schirrmann, Stefan Dübel, & John C. Krauss. (2009). Ribonucleases and ImmunoRNases as Anticancer Drugs. Current Pharmaceutical Design. 15(23). 2665–2675. 25 indexed citations
15.
Schirrmann, Thomas, Jürgen Krauß, Michaela A.E. Arndt, Susanna M. Rybak, & Stefan Dübel. (2008). Targeted therapeutic RNases (ImmunoRNases). Expert Opinion on Biological Therapy. 9(1). 79–95. 43 indexed citations
16.
Bimczok, Diane, et al.. (2008). Short chain regioselectively hydrolyzed scleroglucans induce maturation of porcine dendritic cells. Applied Microbiology and Biotechnology. 82(2). 321–331. 14 indexed citations
17.
Kügler, Jonas, et al.. (2008). Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display. Applied Microbiology and Biotechnology. 80(3). 447–58. 29 indexed citations
18.
Schirrmann, Thomas, et al.. (2007). Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microbial Cell Factories. 6(1). 38–38. 25 indexed citations
19.
Schirrmann, Thomas & Gabriele Pecher. (2004). Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor. Leukemia Research. 29(3). 301–306. 46 indexed citations
20.
Schirrmann, Thomas & Gabriele Pecher. (2001). Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transfer. Cancer Immunology Immunotherapy. 50(10). 549–556. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Frenzel Breakdown of academic impact, for papers by Dirk Saerens Breakdown of academic impact, for papers by John McCafferty Breakdown of academic impact, for papers by Angray S. Kang Breakdown of academic impact, for papers by Hans J. de Haard Breakdown of academic impact, for papers by Shalom Stahl Breakdown of academic impact, for papers by Cécile Vincke Breakdown of academic impact, for papers by Emmanuel Bajyana Songa Breakdown of academic impact, for papers by Katja Conrath Breakdown of academic impact, for papers by Ian M. Tomlinson
Rankless by CCL
2026